nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—PRKCE—hypertension	0.285	0.529	CbGaD
Ruxolitinib—BMPR2—hypertension	0.254	0.471	CbGaD
Ruxolitinib—CYP3A4—Guanethidine—hypertension	0.00544	0.11	CbGbCtD
Ruxolitinib—CYP3A4—Hydralazine—hypertension	0.00412	0.0837	CbGbCtD
Ruxolitinib—CYP3A4—Guanfacine—hypertension	0.00351	0.0712	CbGbCtD
Ruxolitinib—CYP3A4—Isradipine—hypertension	0.00313	0.0634	CbGbCtD
Ruxolitinib—CYP3A4—Nisoldipine—hypertension	0.00275	0.0559	CbGbCtD
Ruxolitinib—CYP3A4—Indapamide—hypertension	0.00275	0.0559	CbGbCtD
Ruxolitinib—CYP3A4—Eplerenone—hypertension	0.00266	0.0539	CbGbCtD
Ruxolitinib—CYP3A4—Diltiazem—hypertension	0.00266	0.0539	CbGbCtD
Ruxolitinib—CYP3A4—Enalapril—hypertension	0.00237	0.0481	CbGbCtD
Ruxolitinib—CYP3A4—Irbesartan—hypertension	0.00217	0.044	CbGbCtD
Ruxolitinib—CYP3A4—Amlodipine—hypertension	0.00212	0.0431	CbGbCtD
Ruxolitinib—CYP3A4—Felodipine—hypertension	0.00205	0.0416	CbGbCtD
Ruxolitinib—CYP3A4—Nifedipine—hypertension	0.00198	0.0402	CbGbCtD
Ruxolitinib—CYP3A4—Carvedilol—hypertension	0.00195	0.0396	CbGbCtD
Ruxolitinib—CYP3A4—Nicardipine—hypertension	0.00195	0.0396	CbGbCtD
Ruxolitinib—CYP3A4—Propranolol—hypertension	0.00179	0.0364	CbGbCtD
Ruxolitinib—CYP3A4—Clonidine—hypertension	0.00171	0.0348	CbGbCtD
Ruxolitinib—CYP3A4—Atorvastatin—hypertension	0.00153	0.031	CbGbCtD
Ruxolitinib—CYP3A4—Losartan—hypertension	0.0014	0.0283	CbGbCtD
Ruxolitinib—CYP3A4—Verapamil—hypertension	0.00123	0.025	CbGbCtD
Ruxolitinib—TAOK2—heart—hypertension	0.000462	0.00468	CbGeAlD
Ruxolitinib—HIPK2—brainstem—hypertension	0.000455	0.00461	CbGeAlD
Ruxolitinib—PRKCE—endocrine gland—hypertension	0.000444	0.0045	CbGeAlD
Ruxolitinib—JAK1—nephron tubule—hypertension	0.000443	0.00449	CbGeAlD
Ruxolitinib—JAK1—adrenal cortex—hypertension	0.000436	0.00442	CbGeAlD
Ruxolitinib—MAP3K7—cardiac ventricle—hypertension	0.000432	0.00438	CbGeAlD
Ruxolitinib—PRKG2—central nervous system—hypertension	0.000428	0.00434	CbGeAlD
Ruxolitinib—PLK1—endocrine gland—hypertension	0.000426	0.00432	CbGeAlD
Ruxolitinib—RPS6KA6—endocrine gland—hypertension	0.000426	0.00432	CbGeAlD
Ruxolitinib—TYK2—cardiac ventricle—hypertension	0.000425	0.00431	CbGeAlD
Ruxolitinib—JAK3—heart—hypertension	0.000424	0.0043	CbGeAlD
Ruxolitinib—JAK1—heart—hypertension	0.000422	0.00427	CbGeAlD
Ruxolitinib—DCLK1—heart—hypertension	0.000422	0.00427	CbGeAlD
Ruxolitinib—IRAK1—cardiac ventricle—hypertension	0.000419	0.00425	CbGeAlD
Ruxolitinib—MKNK2—cardiac ventricle—hypertension	0.000419	0.00425	CbGeAlD
Ruxolitinib—JAK1—smooth muscle tissue—hypertension	0.000418	0.00424	CbGeAlD
Ruxolitinib—DAPK2—adrenal cortex—hypertension	0.000416	0.00422	CbGeAlD
Ruxolitinib—CAMK1—medulla oblongata—hypertension	0.000414	0.0042	CbGeAlD
Ruxolitinib—HIPK2—nephron tubule—hypertension	0.000414	0.00419	CbGeAlD
Ruxolitinib—CAMK1D—heart—hypertension	0.000412	0.00417	CbGeAlD
Ruxolitinib—PLK3—adrenal gland—hypertension	0.00041	0.00416	CbGeAlD
Ruxolitinib—JAK1—decidua—hypertension	0.00041	0.00416	CbGeAlD
Ruxolitinib—DYRK1A—brainstem—hypertension	0.000409	0.00415	CbGeAlD
Ruxolitinib—PHKG2—heart—hypertension	0.000409	0.00415	CbGeAlD
Ruxolitinib—GRK1—central nervous system—hypertension	0.000408	0.00414	CbGeAlD
Ruxolitinib—BMPR2—brainstem—hypertension	0.000408	0.00413	CbGeAlD
Ruxolitinib—MAP3K7—myocardium—hypertension	0.000407	0.00412	CbGeAlD
Ruxolitinib—DAPK2—heart—hypertension	0.000402	0.00408	CbGeAlD
Ruxolitinib—PRKCE—central nervous system—hypertension	0.0004	0.00405	CbGeAlD
Ruxolitinib—TYK2—myocardium—hypertension	0.000399	0.00405	CbGeAlD
Ruxolitinib—JAK1—cardiovascular system—hypertension	0.000398	0.00403	CbGeAlD
Ruxolitinib—STK16—heart—hypertension	0.000396	0.00401	CbGeAlD
Ruxolitinib—IRAK1—myocardium—hypertension	0.000394	0.004	CbGeAlD
Ruxolitinib—MKNK2—myocardium—hypertension	0.000394	0.004	CbGeAlD
Ruxolitinib—HIPK2—heart—hypertension	0.000394	0.00399	CbGeAlD
Ruxolitinib—JAK1—kidney—hypertension	0.000389	0.00395	CbGeAlD
Ruxolitinib—CLK2—adrenal cortex—hypertension	0.000387	0.00393	CbGeAlD
Ruxolitinib—JAK2—cardiac ventricle—hypertension	0.000386	0.00392	CbGeAlD
Ruxolitinib—RPS6KA6—central nervous system—hypertension	0.000384	0.00389	CbGeAlD
Ruxolitinib—PLK1—central nervous system—hypertension	0.000384	0.00389	CbGeAlD
Ruxolitinib—MAST1—central nervous system—hypertension	0.000384	0.00389	CbGeAlD
Ruxolitinib—CAMK1—adrenal gland—hypertension	0.000384	0.00389	CbGeAlD
Ruxolitinib—JAK1—cortex of kidney—hypertension	0.000379	0.00384	CbGeAlD
Ruxolitinib—DAPK3—heart—hypertension	0.000378	0.00383	CbGeAlD
Ruxolitinib—DAPK3—smooth muscle tissue—hypertension	0.000375	0.0038	CbGeAlD
Ruxolitinib—CLK2—heart—hypertension	0.000375	0.0038	CbGeAlD
Ruxolitinib—MARK2—adrenal gland—hypertension	0.000372	0.00378	CbGeAlD
Ruxolitinib—MAP3K3—cardiac ventricle—hypertension	0.000372	0.00378	CbGeAlD
Ruxolitinib—HIPK2—cardiovascular system—hypertension	0.000371	0.00377	CbGeAlD
Ruxolitinib—DAPK3—decidua—hypertension	0.000368	0.00373	CbGeAlD
Ruxolitinib—CAMK2G—brainstem—hypertension	0.000365	0.0037	CbGeAlD
Ruxolitinib—CLK2—decidua—hypertension	0.000364	0.00369	CbGeAlD
Ruxolitinib—DCLK3—central nervous system—hypertension	0.000364	0.00369	CbGeAlD
Ruxolitinib—HIPK2—kidney—hypertension	0.000363	0.00368	CbGeAlD
Ruxolitinib—JAK2—myocardium—hypertension	0.000363	0.00368	CbGeAlD
Ruxolitinib—ROCK1—heart—hypertension	0.000363	0.00368	CbGeAlD
Ruxolitinib—PLK1—Amlodipine—Isradipine—hypertension	0.000362	0.143	CbGdCrCtD
Ruxolitinib—LRRK2—brainstem—hypertension	0.000362	0.00367	CbGeAlD
Ruxolitinib—DAPK2—cortex of kidney—hypertension	0.000362	0.00367	CbGeAlD
Ruxolitinib—JAK1—cardiac atrium—hypertension	0.000361	0.00366	CbGeAlD
Ruxolitinib—ROCK1—smooth muscle tissue—hypertension	0.00036	0.00365	CbGeAlD
Ruxolitinib—PLK1—Fluvastatin—Atorvastatin—hypertension	0.000357	0.141	CbGdCrCtD
Ruxolitinib—DAPK3—cardiovascular system—hypertension	0.000357	0.00362	CbGeAlD
Ruxolitinib—PLK3—endocrine gland—hypertension	0.000356	0.00361	CbGeAlD
Ruxolitinib—DYRK1A—heart—hypertension	0.000354	0.00359	CbGeAlD
Ruxolitinib—NUAK2—nephron tubule—hypertension	0.000354	0.00359	CbGeAlD
Ruxolitinib—HIPK2—cortex of kidney—hypertension	0.000354	0.00359	CbGeAlD
Ruxolitinib—BMPR2—heart—hypertension	0.000353	0.00358	CbGeAlD
Ruxolitinib—CAMK1D—cardiac atrium—hypertension	0.000352	0.00357	CbGeAlD
Ruxolitinib—MAP3K3—myocardium—hypertension	0.00035	0.00355	CbGeAlD
Ruxolitinib—BMPR2—smooth muscle tissue—hypertension	0.00035	0.00355	CbGeAlD
Ruxolitinib—PLK1—Amlodipine—Nisoldipine—hypertension	0.000347	0.137	CbGdCrCtD
Ruxolitinib—PLK1—Amlodipine—Nicardipine—hypertension	0.000347	0.137	CbGdCrCtD
Ruxolitinib—PLK1—Amlodipine—Felodipine—hypertension	0.000347	0.137	CbGdCrCtD
Ruxolitinib—PLK1—Amlodipine—Nifedipine—hypertension	0.000347	0.137	CbGdCrCtD
Ruxolitinib—TAOK2—adrenal gland—hypertension	0.000345	0.00349	CbGeAlD
Ruxolitinib—DYRK1A—decidua—hypertension	0.000344	0.00349	CbGeAlD
Ruxolitinib—DAPK2—cardiac atrium—hypertension	0.000344	0.00349	CbGeAlD
Ruxolitinib—BMPR2—decidua—hypertension	0.000343	0.00348	CbGeAlD
Ruxolitinib—ROCK1—cardiovascular system—hypertension	0.000343	0.00347	CbGeAlD
Ruxolitinib—JAK1—medulla oblongata—hypertension	0.00034	0.00345	CbGeAlD
Ruxolitinib—DCLK1—medulla oblongata—hypertension	0.00034	0.00345	CbGeAlD
Ruxolitinib—TAOK3—cardiac ventricle—hypertension	0.00034	0.00344	CbGeAlD
Ruxolitinib—CLK2—cortex of kidney—hypertension	0.000337	0.00342	CbGeAlD
Ruxolitinib—ROCK1—kidney—hypertension	0.000335	0.0034	CbGeAlD
Ruxolitinib—DYRK1A—cardiovascular system—hypertension	0.000334	0.00339	CbGeAlD
Ruxolitinib—BMPR2—cardiovascular system—hypertension	0.000333	0.00337	CbGeAlD
Ruxolitinib—CAMK1—endocrine gland—hypertension	0.000333	0.00337	CbGeAlD
Ruxolitinib—CAMK1D—medulla oblongata—hypertension	0.000332	0.00336	CbGeAlD
Ruxolitinib—PHKG2—medulla oblongata—hypertension	0.00033	0.00334	CbGeAlD
Ruxolitinib—NUAK2—decidua—hypertension	0.000328	0.00332	CbGeAlD
Ruxolitinib—DYRK1A—kidney—hypertension	0.000327	0.00331	CbGeAlD
Ruxolitinib—BMPR2—kidney—hypertension	0.000326	0.0033	CbGeAlD
Ruxolitinib—DAPK2—medulla oblongata—hypertension	0.000324	0.00329	CbGeAlD
Ruxolitinib—DAPK3—cardiac atrium—hypertension	0.000323	0.00328	CbGeAlD
Ruxolitinib—MARK2—endocrine gland—hypertension	0.000323	0.00327	CbGeAlD
Ruxolitinib—PLK3—central nervous system—hypertension	0.000321	0.00325	CbGeAlD
Ruxolitinib—CLK2—cardiac atrium—hypertension	0.00032	0.00325	CbGeAlD
Ruxolitinib—TAOK3—myocardium—hypertension	0.000319	0.00324	CbGeAlD
Ruxolitinib—BMPR2—cortex of kidney—hypertension	0.000317	0.00322	CbGeAlD
Ruxolitinib—JAK3—adrenal gland—hypertension	0.000317	0.00321	CbGeAlD
Ruxolitinib—CAMK2G—heart—hypertension	0.000316	0.0032	CbGeAlD
Ruxolitinib—BMP2K—heart—hypertension	0.000316	0.0032	CbGeAlD
Ruxolitinib—JAK1—adrenal gland—hypertension	0.000315	0.00319	CbGeAlD
Ruxolitinib—DCLK1—adrenal gland—hypertension	0.000315	0.00319	CbGeAlD
Ruxolitinib—LRRK2—heart—hypertension	0.000313	0.00317	CbGeAlD
Ruxolitinib—PLK4—adrenal gland—hypertension	0.000313	0.00317	CbGeAlD
Ruxolitinib—CAMK1D—adrenal gland—hypertension	0.000307	0.00311	CbGeAlD
Ruxolitinib—BMP2K—decidua—hypertension	0.000307	0.00311	CbGeAlD
Ruxolitinib—PHKG2—adrenal gland—hypertension	0.000305	0.0031	CbGeAlD
Ruxolitinib—DAPK3—medulla oblongata—hypertension	0.000305	0.00309	CbGeAlD
Ruxolitinib—LRRK2—decidua—hypertension	0.000304	0.00308	CbGeAlD
Ruxolitinib—NUAK2—cortex of kidney—hypertension	0.000303	0.00307	CbGeAlD
Ruxolitinib—BMPR2—cardiac atrium—hypertension	0.000302	0.00306	CbGeAlD
Ruxolitinib—MAP3K2—nephron tubule—hypertension	0.000301	0.00305	CbGeAlD
Ruxolitinib—DAPK2—adrenal gland—hypertension	0.0003	0.00304	CbGeAlD
Ruxolitinib—CAMK1—central nervous system—hypertension	0.0003	0.00304	CbGeAlD
Ruxolitinib—CAMK2G—cardiovascular system—hypertension	0.000298	0.00302	CbGeAlD
Ruxolitinib—STK16—adrenal gland—hypertension	0.000295	0.00299	CbGeAlD
Ruxolitinib—HIPK2—adrenal gland—hypertension	0.000294	0.00298	CbGeAlD
Ruxolitinib—MAP3K7—adrenal cortex—hypertension	0.000294	0.00298	CbGeAlD
Ruxolitinib—TYK2—nephron tubule—hypertension	0.000293	0.00297	CbGeAlD
Ruxolitinib—PLK1—Pitavastatin—Atorvastatin—hypertension	0.000291	0.115	CbGdCrCtD
Ruxolitinib—MARK2—central nervous system—hypertension	0.000291	0.00295	CbGeAlD
Ruxolitinib—IRAK1—nephron tubule—hypertension	0.000289	0.00293	CbGeAlD
Ruxolitinib—MKNK2—nephron tubule—hypertension	0.000289	0.00293	CbGeAlD
Ruxolitinib—LRRK2—kidney—hypertension	0.000289	0.00293	CbGeAlD
Ruxolitinib—TYK2—adrenal cortex—hypertension	0.000288	0.00292	CbGeAlD
Ruxolitinib—MAP3K2—heart—hypertension	0.000287	0.00291	CbGeAlD
Ruxolitinib—MKNK2—adrenal cortex—hypertension	0.000285	0.00288	CbGeAlD
Ruxolitinib—BMPR2—medulla oblongata—hypertension	0.000284	0.00288	CbGeAlD
Ruxolitinib—MAP3K7—heart—hypertension	0.000284	0.00288	CbGeAlD
Ruxolitinib—CAMK2G—cortex of kidney—hypertension	0.000284	0.00288	CbGeAlD
Ruxolitinib—DAPK3—adrenal gland—hypertension	0.000282	0.00286	CbGeAlD
Ruxolitinib—MAP3K7—smooth muscle tissue—hypertension	0.000282	0.00286	CbGeAlD
Ruxolitinib—LRRK2—cortex of kidney—hypertension	0.000281	0.00285	CbGeAlD
Ruxolitinib—CLK2—adrenal gland—hypertension	0.00028	0.00283	CbGeAlD
Ruxolitinib—TYK2—heart—hypertension	0.000279	0.00283	CbGeAlD
Ruxolitinib—TYK2—smooth muscle tissue—hypertension	0.000277	0.0028	CbGeAlD
Ruxolitinib—MAP3K7—decidua—hypertension	0.000276	0.0028	CbGeAlD
Ruxolitinib—MKNK2—heart—hypertension	0.000275	0.00279	CbGeAlD
Ruxolitinib—IRAK1—heart—hypertension	0.000275	0.00279	CbGeAlD
Ruxolitinib—JAK3—endocrine gland—hypertension	0.000275	0.00278	CbGeAlD
Ruxolitinib—IRAK1—smooth muscle tissue—hypertension	0.000273	0.00277	CbGeAlD
Ruxolitinib—MKNK2—smooth muscle tissue—hypertension	0.000273	0.00277	CbGeAlD
Ruxolitinib—JAK1—endocrine gland—hypertension	0.000273	0.00277	CbGeAlD
Ruxolitinib—DCLK1—endocrine gland—hypertension	0.000273	0.00277	CbGeAlD
Ruxolitinib—PLK4—endocrine gland—hypertension	0.000271	0.00275	CbGeAlD
Ruxolitinib—TYK2—decidua—hypertension	0.000271	0.00275	CbGeAlD
Ruxolitinib—RET—heart—hypertension	0.000268	0.00272	CbGeAlD
Ruxolitinib—MKNK2—decidua—hypertension	0.000268	0.00271	CbGeAlD
Ruxolitinib—IRAK1—decidua—hypertension	0.000268	0.00271	CbGeAlD
Ruxolitinib—CAMK1D—endocrine gland—hypertension	0.000266	0.0027	CbGeAlD
Ruxolitinib—PHKG2—endocrine gland—hypertension	0.000265	0.00268	CbGeAlD
Ruxolitinib—DYRK1A—adrenal gland—hypertension	0.000264	0.00268	CbGeAlD
Ruxolitinib—CYP3A4—urine—hypertension	0.000264	0.00268	CbGeAlD
Ruxolitinib—BMPR2—adrenal gland—hypertension	0.000263	0.00267	CbGeAlD
Ruxolitinib—TYK2—cardiovascular system—hypertension	0.000263	0.00267	CbGeAlD
Ruxolitinib—RET—decidua—hypertension	0.000261	0.00265	CbGeAlD
Ruxolitinib—MKNK2—cardiovascular system—hypertension	0.00026	0.00263	CbGeAlD
Ruxolitinib—TAOK3—brainstem—hypertension	0.000258	0.00261	CbGeAlD
Ruxolitinib—TYK2—kidney—hypertension	0.000257	0.00261	CbGeAlD
Ruxolitinib—MAP3K3—nephron tubule—hypertension	0.000257	0.0026	CbGeAlD
Ruxolitinib—STK16—endocrine gland—hypertension	0.000256	0.0026	CbGeAlD
Ruxolitinib—MAP3K7—cortex of kidney—hypertension	0.000255	0.00259	CbGeAlD
Ruxolitinib—HIPK2—endocrine gland—hypertension	0.000255	0.00258	CbGeAlD
Ruxolitinib—CAMK2G—medulla oblongata—hypertension	0.000254	0.00258	CbGeAlD
Ruxolitinib—JAK2—heart—hypertension	0.000254	0.00257	CbGeAlD
Ruxolitinib—MAP3K3—adrenal cortex—hypertension	0.000253	0.00256	CbGeAlD
Ruxolitinib—LRRK2—medulla oblongata—hypertension	0.000252	0.00256	CbGeAlD
Ruxolitinib—JAK2—smooth muscle tissue—hypertension	0.000252	0.00255	CbGeAlD
Ruxolitinib—NUAK2—adrenal gland—hypertension	0.000252	0.00255	CbGeAlD
Ruxolitinib—TYK2—cortex of kidney—hypertension	0.000251	0.00254	CbGeAlD
Ruxolitinib—RET—kidney—hypertension	0.000248	0.00251	CbGeAlD
Ruxolitinib—JAK3—central nervous system—hypertension	0.000247	0.00251	CbGeAlD
Ruxolitinib—IRAK1—cortex of kidney—hypertension	0.000247	0.00251	CbGeAlD
Ruxolitinib—MKNK2—cortex of kidney—hypertension	0.000247	0.00251	CbGeAlD
Ruxolitinib—JAK2—decidua—hypertension	0.000247	0.0025	CbGeAlD
Ruxolitinib—JAK1—central nervous system—hypertension	0.000246	0.00249	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—hypertension	0.000246	0.00249	CbGeAlD
Ruxolitinib—DAPK3—endocrine gland—hypertension	0.000245	0.00248	CbGeAlD
Ruxolitinib—MAP3K3—heart—hypertension	0.000244	0.00248	CbGeAlD
Ruxolitinib—MAP3K7—cardiac atrium—hypertension	0.000243	0.00246	CbGeAlD
Ruxolitinib—CLK2—endocrine gland—hypertension	0.000242	0.00246	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—hypertension	0.00024	0.00243	CbGeAlD
Ruxolitinib—JAK2—cardiovascular system—hypertension	0.000239	0.00243	CbGeAlD
Ruxolitinib—PHKG2—central nervous system—hypertension	0.000239	0.00242	CbGeAlD
Ruxolitinib—TYK2—cardiac atrium—hypertension	0.000238	0.00242	CbGeAlD
Ruxolitinib—MAP3K3—decidua—hypertension	0.000238	0.00241	CbGeAlD
Ruxolitinib—BMP2K—adrenal gland—hypertension	0.000236	0.00239	CbGeAlD
Ruxolitinib—CAMK2G—adrenal gland—hypertension	0.000236	0.00239	CbGeAlD
Ruxolitinib—MKNK2—cardiac atrium—hypertension	0.000235	0.00239	CbGeAlD
Ruxolitinib—ROCK1—endocrine gland—hypertension	0.000235	0.00238	CbGeAlD
Ruxolitinib—JAK2—kidney—hypertension	0.000234	0.00237	CbGeAlD
Ruxolitinib—TAOK3—nephron tubule—hypertension	0.000234	0.00237	CbGeAlD
Ruxolitinib—LRRK2—adrenal gland—hypertension	0.000233	0.00237	CbGeAlD
Ruxolitinib—STK16—central nervous system—hypertension	0.000231	0.00234	CbGeAlD
Ruxolitinib—MAP3K3—cardiovascular system—hypertension	0.000231	0.00234	CbGeAlD
Ruxolitinib—TAOK3—adrenal cortex—hypertension	0.00023	0.00234	CbGeAlD
Ruxolitinib—HIPK2—central nervous system—hypertension	0.00023	0.00233	CbGeAlD
Ruxolitinib—DYRK1A—endocrine gland—hypertension	0.000229	0.00232	CbGeAlD
Ruxolitinib—MAP3K7—medulla oblongata—hypertension	0.000229	0.00232	CbGeAlD
Ruxolitinib—BMPR2—endocrine gland—hypertension	0.000228	0.00231	CbGeAlD
Ruxolitinib—JAK2—cortex of kidney—hypertension	0.000228	0.00231	CbGeAlD
Ruxolitinib—MAP3K19—central nervous system—hypertension	0.000225	0.00228	CbGeAlD
Ruxolitinib—TYK2—medulla oblongata—hypertension	0.000225	0.00228	CbGeAlD
Ruxolitinib—TAOK3—heart—hypertension	0.000223	0.00226	CbGeAlD
Ruxolitinib—MKNK2—medulla oblongata—hypertension	0.000222	0.00225	CbGeAlD
Ruxolitinib—DAPK3—central nervous system—hypertension	0.000221	0.00224	CbGeAlD
Ruxolitinib—MAP3K3—cortex of kidney—hypertension	0.00022	0.00223	CbGeAlD
Ruxolitinib—CLK2—central nervous system—hypertension	0.000219	0.00222	CbGeAlD
Ruxolitinib—JAK2—cardiac atrium—hypertension	0.000217	0.0022	CbGeAlD
Ruxolitinib—TAOK3—decidua—hypertension	0.000217	0.0022	CbGeAlD
Ruxolitinib—RET—medulla oblongata—hypertension	0.000216	0.00219	CbGeAlD
Ruxolitinib—MAP3K2—adrenal gland—hypertension	0.000214	0.00217	CbGeAlD
Ruxolitinib—MAP3K7—adrenal gland—hypertension	0.000212	0.00215	CbGeAlD
Ruxolitinib—ROCK1—central nervous system—hypertension	0.000212	0.00215	CbGeAlD
Ruxolitinib—TAOK3—cardiovascular system—hypertension	0.00021	0.00213	CbGeAlD
Ruxolitinib—MAP3K3—cardiac atrium—hypertension	0.000209	0.00212	CbGeAlD
Ruxolitinib—TYK2—adrenal gland—hypertension	0.000208	0.00211	CbGeAlD
Ruxolitinib—DYRK1A—central nervous system—hypertension	0.000207	0.00209	CbGeAlD
Ruxolitinib—TAOK3—kidney—hypertension	0.000206	0.00209	CbGeAlD
Ruxolitinib—BMPR2—central nervous system—hypertension	0.000206	0.00209	CbGeAlD
Ruxolitinib—IRAK1—adrenal gland—hypertension	0.000205	0.00208	CbGeAlD
Ruxolitinib—MKNK2—adrenal gland—hypertension	0.000205	0.00208	CbGeAlD
Ruxolitinib—JAK2—medulla oblongata—hypertension	0.000205	0.00207	CbGeAlD
Ruxolitinib—BMP2K—endocrine gland—hypertension	0.000204	0.00207	CbGeAlD
Ruxolitinib—CAMK2G—endocrine gland—hypertension	0.000204	0.00207	CbGeAlD
Ruxolitinib—LRRK2—endocrine gland—hypertension	0.000202	0.00205	CbGeAlD
Ruxolitinib—TAOK3—cortex of kidney—hypertension	0.0002	0.00203	CbGeAlD
Ruxolitinib—RET—adrenal gland—hypertension	0.0002	0.00203	CbGeAlD
Ruxolitinib—MAP3K3—medulla oblongata—hypertension	0.000197	0.002	CbGeAlD
Ruxolitinib—TAOK3—cardiac atrium—hypertension	0.000191	0.00193	CbGeAlD
Ruxolitinib—JAK2—adrenal gland—hypertension	0.000189	0.00192	CbGeAlD
Ruxolitinib—MAP3K2—endocrine gland—hypertension	0.000186	0.00188	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—hypertension	0.000184	0.00187	CbGeAlD
Ruxolitinib—BMP2K—central nervous system—hypertension	0.000184	0.00187	CbGeAlD
Ruxolitinib—MAP3K3—adrenal gland—hypertension	0.000182	0.00185	CbGeAlD
Ruxolitinib—LRRK2—central nervous system—hypertension	0.000182	0.00185	CbGeAlD
Ruxolitinib—TYK2—endocrine gland—hypertension	0.00018	0.00183	CbGeAlD
Ruxolitinib—TAOK3—medulla oblongata—hypertension	0.00018	0.00182	CbGeAlD
Ruxolitinib—MKNK2—endocrine gland—hypertension	0.000178	0.00181	CbGeAlD
Ruxolitinib—RET—endocrine gland—hypertension	0.000174	0.00176	CbGeAlD
Ruxolitinib—MAP3K2—central nervous system—hypertension	0.000167	0.00169	CbGeAlD
Ruxolitinib—TAOK3—adrenal gland—hypertension	0.000166	0.00169	CbGeAlD
Ruxolitinib—JAK2—endocrine gland—hypertension	0.000164	0.00166	CbGeAlD
Ruxolitinib—TYK2—central nervous system—hypertension	0.000163	0.00165	CbGeAlD
Ruxolitinib—MKNK2—central nervous system—hypertension	0.000161	0.00163	CbGeAlD
Ruxolitinib—MAP3K3—endocrine gland—hypertension	0.000158	0.0016	CbGeAlD
Ruxolitinib—RET—central nervous system—hypertension	0.000157	0.00159	CbGeAlD
Ruxolitinib—JAK2—central nervous system—hypertension	0.000148	0.0015	CbGeAlD
Ruxolitinib—TAOK3—endocrine gland—hypertension	0.000144	0.00146	CbGeAlD
Ruxolitinib—MAP3K3—central nervous system—hypertension	0.000143	0.00145	CbGeAlD
Ruxolitinib—TAOK3—central nervous system—hypertension	0.00013	0.00132	CbGeAlD
Ruxolitinib—PLK1—Terbinafine—Propranolol—hypertension	0.000129	0.0512	CbGdCrCtD
Ruxolitinib—Anaemia—Irbesartan—hypertension	0.000114	0.000871	CcSEcCtD
Ruxolitinib—Skin disorder—Valsartan—hypertension	0.000113	0.000869	CcSEcCtD
Ruxolitinib—Asthenia—Amlodipine—hypertension	0.000113	0.000868	CcSEcCtD
Ruxolitinib—Headache—Felodipine—hypertension	0.000113	0.000866	CcSEcCtD
Ruxolitinib—Headache—Metolazone—hypertension	0.000113	0.000866	CcSEcCtD
Ruxolitinib—Skin disorder—Olmesartan—hypertension	0.000113	0.000865	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Carvedilol—hypertension	0.000113	0.000864	CcSEcCtD
Ruxolitinib—Anaemia—Hydrochlorothiazide—hypertension	0.000113	0.000863	CcSEcCtD
Ruxolitinib—Headache—Spironolactone—hypertension	0.000113	0.000863	CcSEcCtD
Ruxolitinib—Fatigue—Carvedilol—hypertension	0.000113	0.000863	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—hypertension	0.000112	0.000861	CcSEcCtD
Ruxolitinib—Dizziness—Acebutolol—hypertension	0.000112	0.000859	CcSEcCtD
Ruxolitinib—Urinary tract infection—Lisinopril—hypertension	0.000112	0.000857	CcSEcCtD
Ruxolitinib—Pruritus—Nisoldipine—hypertension	0.000112	0.000856	CcSEcCtD
Ruxolitinib—Pruritus—Amlodipine—hypertension	0.000112	0.000856	CcSEcCtD
Ruxolitinib—Fatigue—Doxazosin—hypertension	0.000111	0.000854	CcSEcCtD
Ruxolitinib—Dizziness—Labetalol—hypertension	0.000111	0.000851	CcSEcCtD
Ruxolitinib—Anaemia—Furosemide—hypertension	0.000111	0.000849	CcSEcCtD
Ruxolitinib—Infection—Clonidine—hypertension	0.00011	0.000847	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—hypertension	0.00011	0.000846	CcSEcCtD
Ruxolitinib—Headache—Esmolol—hypertension	0.00011	0.000846	CcSEcCtD
Ruxolitinib—Fatigue—Fosinopril—hypertension	0.00011	0.000843	CcSEcCtD
Ruxolitinib—Haematuria—Lisinopril—hypertension	0.00011	0.000841	CcSEcCtD
Ruxolitinib—Anaemia—Betaxolol—hypertension	0.00011	0.000841	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Eplerenone—hypertension	0.000109	0.000839	CcSEcCtD
Ruxolitinib—Fatigue—Eplerenone—hypertension	0.000109	0.000838	CcSEcCtD
Ruxolitinib—Nervous system disorder—Clonidine—hypertension	0.000109	0.000836	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Clonidine—hypertension	0.000109	0.000835	CcSEcCtD
Ruxolitinib—Headache—Terazosin—hypertension	0.000109	0.000834	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Lisinopril—hypertension	0.000109	0.000834	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Nifedipine—hypertension	0.000109	0.000833	CcSEcCtD
Ruxolitinib—Epistaxis—Lisinopril—hypertension	0.000108	0.000832	CcSEcCtD
Ruxolitinib—Fatigue—Nifedipine—hypertension	0.000108	0.000832	CcSEcCtD
Ruxolitinib—Fatigue—Verapamil—hypertension	0.000108	0.000828	CcSEcCtD
Ruxolitinib—Skin disorder—Clonidine—hypertension	0.000108	0.000828	CcSEcCtD
Ruxolitinib—Infection—Trandolapril—hypertension	0.000108	0.000826	CcSEcCtD
Ruxolitinib—Body temperature increased—Propranolol—hypertension	0.000108	0.000826	CcSEcCtD
Ruxolitinib—Dizziness—Eprosartan—hypertension	0.000107	0.000824	CcSEcCtD
Ruxolitinib—Anaemia—Losartan—hypertension	0.000107	0.000819	CcSEcCtD
Ruxolitinib—Asthenia—Guanabenz—hypertension	0.000106	0.000816	CcSEcCtD
Ruxolitinib—Asthenia—Metoprolol—hypertension	0.000106	0.000816	CcSEcCtD
Ruxolitinib—Nervous system disorder—Trandolapril—hypertension	0.000106	0.000815	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Trandolapril—hypertension	0.000106	0.000814	CcSEcCtD
Ruxolitinib—Headache—Acebutolol—hypertension	0.000106	0.000813	CcSEcCtD
Ruxolitinib—Infection—Telmisartan—hypertension	0.000106	0.000812	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Enalapril—hypertension	0.000106	0.000811	CcSEcCtD
Ruxolitinib—Skin disorder—Trandolapril—hypertension	0.000105	0.000808	CcSEcCtD
Ruxolitinib—Headache—Labetalol—hypertension	0.000105	0.000806	CcSEcCtD
Ruxolitinib—Pruritus—Guanabenz—hypertension	0.000105	0.000805	CcSEcCtD
Ruxolitinib—Pruritus—Metoprolol—hypertension	0.000105	0.000805	CcSEcCtD
Ruxolitinib—Nervous system disorder—Telmisartan—hypertension	0.000104	0.000801	CcSEcCtD
Ruxolitinib—Dizziness—Amlodipine—hypertension	0.000104	0.0008	CcSEcCtD
Ruxolitinib—Dizziness—Nisoldipine—hypertension	0.000104	0.0008	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Telmisartan—hypertension	0.000104	0.0008	CcSEcCtD
Ruxolitinib—Body temperature increased—Indapamide—hypertension	0.000104	0.000799	CcSEcCtD
Ruxolitinib—Body temperature increased—Diltiazem—hypertension	0.000104	0.000799	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Perindopril—hypertension	0.000104	0.000799	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—hypertension	0.000104	0.000796	CcSEcCtD
Ruxolitinib—Skin disorder—Telmisartan—hypertension	0.000103	0.000793	CcSEcCtD
Ruxolitinib—Body temperature increased—Carvedilol—hypertension	0.000103	0.000791	CcSEcCtD
Ruxolitinib—Body temperature increased—Doxazosin—hypertension	0.000102	0.000783	CcSEcCtD
Ruxolitinib—Headache—Eprosartan—hypertension	0.000102	0.000781	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Captopril—hypertension	0.000101	0.000778	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Furosemide—hypertension	0.000101	0.000777	CcSEcCtD
Ruxolitinib—Body temperature increased—Fosinopril—hypertension	0.000101	0.000773	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Valsartan—hypertension	0.000101	0.000772	CcSEcCtD
Ruxolitinib—Fatigue—Valsartan—hypertension	0.000101	0.000771	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—hypertension	0.0001	0.000769	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Olmesartan—hypertension	0.0001	0.000769	CcSEcCtD
Ruxolitinib—Body temperature increased—Eplerenone—hypertension	0.0001	0.000768	CcSEcCtD
Ruxolitinib—Fatigue—Olmesartan—hypertension	0.0001	0.000767	CcSEcCtD
Ruxolitinib—Infection—Irbesartan—hypertension	9.96e-05	0.000764	CcSEcCtD
Ruxolitinib—Body temperature increased—Nifedipine—hypertension	9.95e-05	0.000763	CcSEcCtD
Ruxolitinib—Malnutrition—Ramipril—hypertension	9.91e-05	0.00076	CcSEcCtD
Ruxolitinib—Headache—Nisoldipine—hypertension	9.88e-05	0.000758	CcSEcCtD
Ruxolitinib—Headache—Amlodipine—hypertension	9.88e-05	0.000758	CcSEcCtD
Ruxolitinib—Nervous system disorder—Perindopril—hypertension	9.86e-05	0.000756	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Perindopril—hypertension	9.85e-05	0.000755	CcSEcCtD
Ruxolitinib—Nervous system disorder—Irbesartan—hypertension	9.83e-05	0.000754	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Irbesartan—hypertension	9.81e-05	0.000753	CcSEcCtD
Ruxolitinib—Dizziness—Guanabenz—hypertension	9.81e-05	0.000752	CcSEcCtD
Ruxolitinib—Dizziness—Metoprolol—hypertension	9.81e-05	0.000752	CcSEcCtD
Ruxolitinib—Asthenia—Propranolol—hypertension	9.77e-05	0.000749	CcSEcCtD
Ruxolitinib—Skin disorder—Perindopril—hypertension	9.77e-05	0.000749	CcSEcCtD
Ruxolitinib—Skin disorder—Irbesartan—hypertension	9.73e-05	0.000747	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Hydrochlorothiazide—hypertension	9.73e-05	0.000746	CcSEcCtD
Ruxolitinib—Malnutrition—Timolol—hypertension	9.69e-05	0.000743	CcSEcCtD
Ruxolitinib—Infection—Betaxolol—hypertension	9.61e-05	0.000737	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Clonidine—hypertension	9.6e-05	0.000736	CcSEcCtD
Ruxolitinib—Nervous system disorder—Furosemide—hypertension	9.59e-05	0.000735	CcSEcCtD
Ruxolitinib—Fatigue—Clonidine—hypertension	9.58e-05	0.000735	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Furosemide—hypertension	9.57e-05	0.000734	CcSEcCtD
Ruxolitinib—Skin disorder—Furosemide—hypertension	9.5e-05	0.000728	CcSEcCtD
Ruxolitinib—Nervous system disorder—Betaxolol—hypertension	9.49e-05	0.000728	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Betaxolol—hypertension	9.48e-05	0.000727	CcSEcCtD
Ruxolitinib—Asthenia—Diltiazem—hypertension	9.46e-05	0.000725	CcSEcCtD
Ruxolitinib—Asthenia—Indapamide—hypertension	9.46e-05	0.000725	CcSEcCtD
Ruxolitinib—Skin disorder—Betaxolol—hypertension	9.4e-05	0.000721	CcSEcCtD
Ruxolitinib—Infection—Losartan—hypertension	9.37e-05	0.000719	CcSEcCtD
Ruxolitinib—Asthenia—Carvedilol—hypertension	9.37e-05	0.000718	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Trandolapril—hypertension	9.36e-05	0.000718	CcSEcCtD
Ruxolitinib—Fatigue—Trandolapril—hypertension	9.35e-05	0.000717	CcSEcCtD
Ruxolitinib—Pruritus—Indapamide—hypertension	9.33e-05	0.000715	CcSEcCtD
Ruxolitinib—Pruritus—Diltiazem—hypertension	9.33e-05	0.000715	CcSEcCtD
Ruxolitinib—Fatigue—Enalapril—hypertension	9.31e-05	0.000714	CcSEcCtD
Ruxolitinib—Headache—Guanabenz—hypertension	9.29e-05	0.000713	CcSEcCtD
Ruxolitinib—Headache—Metoprolol—hypertension	9.29e-05	0.000713	CcSEcCtD
Ruxolitinib—Asthenia—Doxazosin—hypertension	9.26e-05	0.00071	CcSEcCtD
Ruxolitinib—Nervous system disorder—Losartan—hypertension	9.25e-05	0.000709	CcSEcCtD
Ruxolitinib—Pruritus—Carvedilol—hypertension	9.23e-05	0.000708	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Losartan—hypertension	9.23e-05	0.000708	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Telmisartan—hypertension	9.2e-05	0.000705	CcSEcCtD
Ruxolitinib—Fatigue—Telmisartan—hypertension	9.18e-05	0.000704	CcSEcCtD
Ruxolitinib—Body temperature increased—Olmesartan—hypertension	9.17e-05	0.000704	CcSEcCtD
Ruxolitinib—Asthenia—Fosinopril—hypertension	9.15e-05	0.000702	CcSEcCtD
Ruxolitinib—Pruritus—Doxazosin—hypertension	9.13e-05	0.0007	CcSEcCtD
Ruxolitinib—Asthenia—Eplerenone—hypertension	9.09e-05	0.000697	CcSEcCtD
Ruxolitinib—Asthenia—Nifedipine—hypertension	9.03e-05	0.000692	CcSEcCtD
Ruxolitinib—Pruritus—Fosinopril—hypertension	9.02e-05	0.000692	CcSEcCtD
Ruxolitinib—Dizziness—Propranolol—hypertension	9e-05	0.000691	CcSEcCtD
Ruxolitinib—Asthenia—Verapamil—hypertension	8.99e-05	0.000689	CcSEcCtD
Ruxolitinib—Malnutrition—Lisinopril—hypertension	8.99e-05	0.000689	CcSEcCtD
Ruxolitinib—Pruritus—Eplerenone—hypertension	8.97e-05	0.000688	CcSEcCtD
Ruxolitinib—Fatigue—Captopril—hypertension	8.93e-05	0.000685	CcSEcCtD
Ruxolitinib—Pruritus—Nifedipine—hypertension	8.9e-05	0.000683	CcSEcCtD
Ruxolitinib—Pruritus—Verapamil—hypertension	8.86e-05	0.00068	CcSEcCtD
Ruxolitinib—Flatulence—Lisinopril—hypertension	8.86e-05	0.000679	CcSEcCtD
Ruxolitinib—Body temperature increased—Clonidine—hypertension	8.79e-05	0.000674	CcSEcCtD
Ruxolitinib—Dizziness—Diltiazem—hypertension	8.72e-05	0.000669	CcSEcCtD
Ruxolitinib—Dizziness—Indapamide—hypertension	8.72e-05	0.000669	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Perindopril—hypertension	8.68e-05	0.000666	CcSEcCtD
Ruxolitinib—Fatigue—Perindopril—hypertension	8.67e-05	0.000665	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Irbesartan—hypertension	8.65e-05	0.000664	CcSEcCtD
Ruxolitinib—Fatigue—Irbesartan—hypertension	8.64e-05	0.000663	CcSEcCtD
Ruxolitinib—Dizziness—Carvedilol—hypertension	8.63e-05	0.000662	CcSEcCtD
Ruxolitinib—Body temperature increased—Trandolapril—hypertension	8.57e-05	0.000657	CcSEcCtD
Ruxolitinib—Fatigue—Hydrochlorothiazide—hypertension	8.57e-05	0.000657	CcSEcCtD
Ruxolitinib—Dizziness—Doxazosin—hypertension	8.54e-05	0.000655	CcSEcCtD
Ruxolitinib—Body temperature increased—Enalapril—hypertension	8.54e-05	0.000655	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Furosemide—hypertension	8.44e-05	0.000647	CcSEcCtD
Ruxolitinib—Dizziness—Fosinopril—hypertension	8.43e-05	0.000647	CcSEcCtD
Ruxolitinib—Fatigue—Furosemide—hypertension	8.43e-05	0.000646	CcSEcCtD
Ruxolitinib—Body temperature increased—Telmisartan—hypertension	8.42e-05	0.000646	CcSEcCtD
Ruxolitinib—Dizziness—Eplerenone—hypertension	8.38e-05	0.000643	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	8.38e-05	0.000643	CcSEcCtD
Ruxolitinib—Asthenia—Valsartan—hypertension	8.37e-05	0.000642	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Betaxolol—hypertension	8.36e-05	0.000641	CcSEcCtD
Ruxolitinib—Fatigue—Betaxolol—hypertension	8.34e-05	0.00064	CcSEcCtD
Ruxolitinib—Asthenia—Olmesartan—hypertension	8.33e-05	0.000639	CcSEcCtD
Ruxolitinib—Dizziness—Nifedipine—hypertension	8.32e-05	0.000638	CcSEcCtD
Ruxolitinib—Anaemia—Lisinopril—hypertension	8.31e-05	0.000637	CcSEcCtD
Ruxolitinib—Dizziness—Verapamil—hypertension	8.28e-05	0.000635	CcSEcCtD
Ruxolitinib—Headache—Indapamide—hypertension	8.26e-05	0.000633	CcSEcCtD
Ruxolitinib—Headache—Diltiazem—hypertension	8.26e-05	0.000633	CcSEcCtD
Ruxolitinib—Pruritus—Valsartan—hypertension	8.25e-05	0.000633	CcSEcCtD
Ruxolitinib—Pruritus—Olmesartan—hypertension	8.21e-05	0.00063	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	8.19e-05	0.000628	CcSEcCtD
Ruxolitinib—Body temperature increased—Captopril—hypertension	8.19e-05	0.000628	CcSEcCtD
Ruxolitinib—Headache—Carvedilol—hypertension	8.18e-05	0.000627	CcSEcCtD
Ruxolitinib—Fatigue—Losartan—hypertension	8.13e-05	0.000624	CcSEcCtD
Ruxolitinib—Headache—Doxazosin—hypertension	8.09e-05	0.00062	CcSEcCtD
Ruxolitinib—Headache—Fosinopril—hypertension	7.99e-05	0.000613	CcSEcCtD
Ruxolitinib—Asthenia—Clonidine—hypertension	7.98e-05	0.000612	CcSEcCtD
Ruxolitinib—Body temperature increased—Perindopril—hypertension	7.95e-05	0.00061	CcSEcCtD
Ruxolitinib—Headache—Eplerenone—hypertension	7.94e-05	0.000609	CcSEcCtD
Ruxolitinib—Nervous system disorder—Ramipril—hypertension	7.93e-05	0.000608	CcSEcCtD
Ruxolitinib—Body temperature increased—Irbesartan—hypertension	7.92e-05	0.000608	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Ramipril—hypertension	7.92e-05	0.000607	CcSEcCtD
Ruxolitinib—Headache—Nifedipine—hypertension	7.88e-05	0.000605	CcSEcCtD
Ruxolitinib—Pruritus—Clonidine—hypertension	7.86e-05	0.000603	CcSEcCtD
Ruxolitinib—Body temperature increased—Hydrochlorothiazide—hypertension	7.86e-05	0.000603	CcSEcCtD
Ruxolitinib—Skin disorder—Ramipril—hypertension	7.86e-05	0.000603	CcSEcCtD
Ruxolitinib—Infection—Timolol—hypertension	7.85e-05	0.000602	CcSEcCtD
Ruxolitinib—Headache—Verapamil—hypertension	7.85e-05	0.000602	CcSEcCtD
Ruxolitinib—Asthenia—Trandolapril—hypertension	7.78e-05	0.000597	CcSEcCtD
Ruxolitinib—Nervous system disorder—Timolol—hypertension	7.75e-05	0.000595	CcSEcCtD
Ruxolitinib—Asthenia—Enalapril—hypertension	7.75e-05	0.000594	CcSEcCtD
Ruxolitinib—Body temperature increased—Furosemide—hypertension	7.73e-05	0.000593	CcSEcCtD
Ruxolitinib—Dizziness—Valsartan—hypertension	7.71e-05	0.000591	CcSEcCtD
Ruxolitinib—Skin disorder—Timolol—hypertension	7.68e-05	0.000589	CcSEcCtD
Ruxolitinib—Dizziness—Olmesartan—hypertension	7.67e-05	0.000589	CcSEcCtD
Ruxolitinib—Pruritus—Trandolapril—hypertension	7.67e-05	0.000588	CcSEcCtD
Ruxolitinib—Body temperature increased—Betaxolol—hypertension	7.65e-05	0.000587	CcSEcCtD
Ruxolitinib—Asthenia—Telmisartan—hypertension	7.64e-05	0.000586	CcSEcCtD
Ruxolitinib—Pruritus—Enalapril—hypertension	7.64e-05	0.000586	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	7.6e-05	0.000583	CcSEcCtD
Ruxolitinib—Pruritus—Telmisartan—hypertension	7.54e-05	0.000578	CcSEcCtD
Ruxolitinib—Body temperature increased—Losartan—hypertension	7.46e-05	0.000572	CcSEcCtD
Ruxolitinib—Asthenia—Captopril—hypertension	7.43e-05	0.00057	CcSEcCtD
Ruxolitinib—Dizziness—Clonidine—hypertension	7.35e-05	0.000564	CcSEcCtD
Ruxolitinib—Pruritus—Captopril—hypertension	7.33e-05	0.000562	CcSEcCtD
Ruxolitinib—Headache—Valsartan—hypertension	7.31e-05	0.00056	CcSEcCtD
Ruxolitinib—Infection—Lisinopril—hypertension	7.29e-05	0.000559	CcSEcCtD
Ruxolitinib—Headache—Olmesartan—hypertension	7.27e-05	0.000558	CcSEcCtD
Ruxolitinib—Asthenia—Perindopril—hypertension	7.21e-05	0.000553	CcSEcCtD
Ruxolitinib—Asthenia—Irbesartan—hypertension	7.19e-05	0.000552	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Lisinopril—hypertension	7.18e-05	0.000551	CcSEcCtD
Ruxolitinib—Dizziness—Trandolapril—hypertension	7.17e-05	0.00055	CcSEcCtD
Ruxolitinib—Dizziness—Enalapril—hypertension	7.14e-05	0.000548	CcSEcCtD
Ruxolitinib—Asthenia—Hydrochlorothiazide—hypertension	7.13e-05	0.000547	CcSEcCtD
Ruxolitinib—Skin disorder—Lisinopril—hypertension	7.12e-05	0.000546	CcSEcCtD
Ruxolitinib—Pruritus—Perindopril—hypertension	7.11e-05	0.000546	CcSEcCtD
Ruxolitinib—Pruritus—Irbesartan—hypertension	7.09e-05	0.000544	CcSEcCtD
Ruxolitinib—Dizziness—Telmisartan—hypertension	7.04e-05	0.00054	CcSEcCtD
Ruxolitinib—Pruritus—Hydrochlorothiazide—hypertension	7.03e-05	0.000539	CcSEcCtD
Ruxolitinib—Asthenia—Furosemide—hypertension	7.01e-05	0.000538	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Ramipril—hypertension	6.98e-05	0.000536	CcSEcCtD
Ruxolitinib—Fatigue—Ramipril—hypertension	6.97e-05	0.000535	CcSEcCtD
Ruxolitinib—Headache—Clonidine—hypertension	6.96e-05	0.000534	CcSEcCtD
Ruxolitinib—Asthenia—Betaxolol—hypertension	6.94e-05	0.000533	CcSEcCtD
Ruxolitinib—Pruritus—Furosemide—hypertension	6.92e-05	0.00053	CcSEcCtD
Ruxolitinib—Dizziness—Captopril—hypertension	6.85e-05	0.000525	CcSEcCtD
Ruxolitinib—Pruritus—Betaxolol—hypertension	6.85e-05	0.000525	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Timolol—hypertension	6.83e-05	0.000524	CcSEcCtD
Ruxolitinib—Fatigue—Timolol—hypertension	6.82e-05	0.000523	CcSEcCtD
Ruxolitinib—Headache—Trandolapril—hypertension	6.79e-05	0.000521	CcSEcCtD
Ruxolitinib—Asthenia—Losartan—hypertension	6.77e-05	0.000519	CcSEcCtD
Ruxolitinib—Headache—Enalapril—hypertension	6.76e-05	0.000519	CcSEcCtD
Ruxolitinib—Pruritus—Losartan—hypertension	6.67e-05	0.000512	CcSEcCtD
Ruxolitinib—Headache—Telmisartan—hypertension	6.67e-05	0.000512	CcSEcCtD
Ruxolitinib—Dizziness—Perindopril—hypertension	6.65e-05	0.00051	CcSEcCtD
Ruxolitinib—Dizziness—Irbesartan—hypertension	6.63e-05	0.000508	CcSEcCtD
Ruxolitinib—Dizziness—Hydrochlorothiazide—hypertension	6.57e-05	0.000504	CcSEcCtD
Ruxolitinib—Headache—Captopril—hypertension	6.49e-05	0.000498	CcSEcCtD
Ruxolitinib—Dizziness—Furosemide—hypertension	6.46e-05	0.000496	CcSEcCtD
Ruxolitinib—Dizziness—Betaxolol—hypertension	6.4e-05	0.000491	CcSEcCtD
Ruxolitinib—Body temperature increased—Ramipril—hypertension	6.39e-05	0.00049	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Lisinopril—hypertension	6.33e-05	0.000486	CcSEcCtD
Ruxolitinib—Fatigue—Lisinopril—hypertension	6.32e-05	0.000485	CcSEcCtD
Ruxolitinib—Headache—Perindopril—hypertension	6.3e-05	0.000483	CcSEcCtD
Ruxolitinib—Headache—Irbesartan—hypertension	6.28e-05	0.000482	CcSEcCtD
Ruxolitinib—CYP3A4—kidney—hypertension	6.25e-05	0.000634	CbGeAlD
Ruxolitinib—Body temperature increased—Timolol—hypertension	6.25e-05	0.000479	CcSEcCtD
Ruxolitinib—Dizziness—Losartan—hypertension	6.24e-05	0.000478	CcSEcCtD
Ruxolitinib—Headache—Hydrochlorothiazide—hypertension	6.23e-05	0.000478	CcSEcCtD
Ruxolitinib—Headache—Furosemide—hypertension	6.12e-05	0.00047	CcSEcCtD
Ruxolitinib—Headache—Betaxolol—hypertension	6.06e-05	0.000465	CcSEcCtD
Ruxolitinib—Headache—Losartan—hypertension	5.91e-05	0.000453	CcSEcCtD
Ruxolitinib—Asthenia—Ramipril—hypertension	5.8e-05	0.000445	CcSEcCtD
Ruxolitinib—Body temperature increased—Lisinopril—hypertension	5.8e-05	0.000445	CcSEcCtD
Ruxolitinib—Pruritus—Ramipril—hypertension	5.72e-05	0.000439	CcSEcCtD
Ruxolitinib—Asthenia—Timolol—hypertension	5.67e-05	0.000435	CcSEcCtD
Ruxolitinib—Pruritus—Timolol—hypertension	5.59e-05	0.000429	CcSEcCtD
Ruxolitinib—Dizziness—Ramipril—hypertension	5.35e-05	0.00041	CcSEcCtD
Ruxolitinib—Asthenia—Lisinopril—hypertension	5.26e-05	0.000404	CcSEcCtD
Ruxolitinib—Dizziness—Timolol—hypertension	5.23e-05	0.000401	CcSEcCtD
Ruxolitinib—Pruritus—Lisinopril—hypertension	5.19e-05	0.000398	CcSEcCtD
Ruxolitinib—Headache—Ramipril—hypertension	5.07e-05	0.000389	CcSEcCtD
Ruxolitinib—Headache—Timolol—hypertension	4.95e-05	0.00038	CcSEcCtD
Ruxolitinib—Dizziness—Lisinopril—hypertension	4.85e-05	0.000372	CcSEcCtD
Ruxolitinib—Headache—Lisinopril—hypertension	4.59e-05	0.000352	CcSEcCtD
Ruxolitinib—CYP3A4—endocrine gland—hypertension	4.38e-05	0.000444	CbGeAlD
Ruxolitinib—CYP3A4—central nervous system—hypertension	3.95e-05	0.0004	CbGeAlD
Ruxolitinib—ROCK1—Signaling by GPCR—AKT1—hypertension	7.84e-07	4.35e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HIF1A—hypertension	7.84e-07	4.35e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—EGFR—hypertension	7.81e-07	4.34e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AGT—hypertension	7.81e-07	4.33e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EP300—hypertension	7.79e-07	4.33e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PIK3R1—hypertension	7.79e-07	4.32e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—hypertension	7.79e-07	4.32e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—AKT1—hypertension	7.77e-07	4.31e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGIS—hypertension	7.75e-07	4.3e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC5A2—hypertension	7.75e-07	4.3e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP3A5—hypertension	7.75e-07	4.3e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—EGFR—hypertension	7.72e-07	4.29e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SERPINE1—hypertension	7.68e-07	4.26e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TP53—hypertension	7.68e-07	4.26e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CALM1—hypertension	7.68e-07	4.26e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF2—hypertension	7.67e-07	4.26e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EP300—hypertension	7.66e-07	4.25e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOE—hypertension	7.65e-07	4.25e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LEP—hypertension	7.65e-07	4.25e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RHOA—hypertension	7.64e-07	4.24e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—hypertension	7.58e-07	4.21e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—EGFR—hypertension	7.58e-07	4.21e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CAV1—hypertension	7.58e-07	4.21e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SRC—hypertension	7.58e-07	4.21e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOA1—hypertension	7.56e-07	4.2e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PIK3R1—hypertension	7.56e-07	4.2e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—hypertension	7.56e-07	4.2e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MTOR—hypertension	7.55e-07	4.19e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—hypertension	7.54e-07	4.19e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—KDR—hypertension	7.49e-07	4.16e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—hypertension	7.49e-07	4.16e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TPH1—hypertension	7.48e-07	4.15e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—UCP3—hypertension	7.48e-07	4.15e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ABCC1—hypertension	7.48e-07	4.15e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HSD11B1—hypertension	7.48e-07	4.15e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—UCP2—hypertension	7.48e-07	4.15e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SRC—hypertension	7.45e-07	4.14e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF2—hypertension	7.44e-07	4.13e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RHOA—hypertension	7.41e-07	4.11e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VEGFA—hypertension	7.38e-07	4.1e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—EGFR—hypertension	7.36e-07	4.08e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PIK3R1—hypertension	7.33e-07	4.07e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—hypertension	7.33e-07	4.07e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RELA—hypertension	7.33e-07	4.07e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—hypertension	7.29e-07	4.05e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—AKT1—hypertension	7.28e-07	4.04e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VEGFA—hypertension	7.26e-07	4.03e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC2A3—hypertension	7.25e-07	4.02e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALAS1—hypertension	7.25e-07	4.02e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP11B2—hypertension	7.25e-07	4.02e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRKCB—hypertension	7.21e-07	4e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—F2—hypertension	7.21e-07	4e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FN1—hypertension	7.21e-07	4e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MTOR—hypertension	7.19e-07	3.99e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MYC—hypertension	7.16e-07	3.97e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFB1—hypertension	7.14e-07	3.96e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HSD3B1—hypertension	7.14e-07	3.96e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADA—hypertension	7.14e-07	3.96e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RELA—hypertension	7.12e-07	3.95e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CDKN1A—hypertension	7.09e-07	3.93e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PTEN—hypertension	7.07e-07	3.92e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOTCH1—hypertension	7.06e-07	3.92e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—FADS1—hypertension	7.04e-07	3.91e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AQP1—hypertension	7.04e-07	3.91e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—hypertension	7.03e-07	3.9e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—EGFR—hypertension	7e-07	3.89e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—AKT1—hypertension	7e-07	3.88e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MTOR—hypertension	6.98e-07	3.87e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—MAPK8—hypertension	6.92e-07	3.84e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CXCL8—hypertension	6.91e-07	3.84e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RELA—hypertension	6.9e-07	3.83e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TBXAS1—hypertension	6.84e-07	3.8e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CA9—hypertension	6.84e-07	3.8e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MYC—hypertension	6.79e-07	3.77e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFB1—hypertension	6.77e-07	3.76e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MTOR—hypertension	6.77e-07	3.76e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—EP300—hypertension	6.74e-07	3.74e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—AKT1—hypertension	6.72e-07	3.73e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CXCL8—hypertension	6.71e-07	3.72e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MYC—hypertension	6.68e-07	3.71e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALOX5AP—hypertension	6.67e-07	3.7e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALOX15—hypertension	6.67e-07	3.7e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFB1—hypertension	6.66e-07	3.7e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EGFR—hypertension	6.64e-07	3.69e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—hypertension	6.57e-07	3.65e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—SRC—hypertension	6.56e-07	3.64e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CDKN1A—hypertension	6.54e-07	3.63e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—INS—hypertension	6.54e-07	3.63e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EGFR—hypertension	6.53e-07	3.63e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTEN—hypertension	6.53e-07	3.62e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LHB—hypertension	6.51e-07	3.61e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HADHA—hypertension	6.51e-07	3.61e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CXCL8—hypertension	6.51e-07	3.61e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AKT1—hypertension	6.49e-07	3.6e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TP53—hypertension	6.48e-07	3.6e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL2—hypertension	6.43e-07	3.57e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—hypertension	6.38e-07	3.54e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—KCNJ11—hypertension	6.36e-07	3.53e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HSD3B2—hypertension	6.36e-07	3.53e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LPA—hypertension	6.36e-07	3.53e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF1—hypertension	6.32e-07	3.51e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AKT2—hypertension	6.32e-07	3.51e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—EGFR—hypertension	6.29e-07	3.49e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—hypertension	6.25e-07	3.47e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CDKN1A—hypertension	6.23e-07	3.46e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—EP300—hypertension	6.23e-07	3.46e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PTEN—hypertension	6.21e-07	3.45e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LRP2—hypertension	6.1e-07	3.39e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP2C18—hypertension	6.1e-07	3.39e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MAPK8—hypertension	6.08e-07	3.37e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—hypertension	6.07e-07	3.37e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SRC—hypertension	6.05e-07	3.36e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CDKN1A—hypertension	6.05e-07	3.36e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PTEN—hypertension	6.03e-07	3.35e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—hypertension	6e-07	3.33e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SERPINE1—hypertension	6e-07	3.33e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—hypertension	5.93e-07	3.29e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EP300—hypertension	5.93e-07	3.29e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MAPK8—hypertension	5.9e-07	3.28e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—hypertension	5.88e-07	3.27e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AKT1—hypertension	5.88e-07	3.27e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HSPG2—hypertension	5.87e-07	3.26e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CDKN1A—hypertension	5.86e-07	3.26e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PTEN—hypertension	5.85e-07	3.25e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—hypertension	5.83e-07	3.24e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF2—hypertension	5.81e-07	3.23e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RHOA—hypertension	5.79e-07	3.21e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SRC—hypertension	5.76e-07	3.2e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EP300—hypertension	5.75e-07	3.19e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—EGFR—hypertension	5.75e-07	3.19e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—hypertension	5.73e-07	3.18e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PIK3R1—hypertension	5.73e-07	3.18e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MAPK8—hypertension	5.72e-07	3.18e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GLP1R—hypertension	5.67e-07	3.15e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALOX5—hypertension	5.67e-07	3.15e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—hypertension	5.65e-07	3.14e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VEGFA—hypertension	5.61e-07	3.12e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SRC—hypertension	5.59e-07	3.11e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EP300—hypertension	5.58e-07	3.1e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TP53—hypertension	5.58e-07	3.1e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—AKT1—hypertension	5.54e-07	3.07e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TP53—hypertension	5.48e-07	3.04e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AKT1—hypertension	5.47e-07	3.04e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VEGFA—hypertension	5.45e-07	3.02e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SRC—hypertension	5.43e-07	3.01e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MYC—hypertension	5.43e-07	3.01e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFB1—hypertension	5.41e-07	3e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RELA—hypertension	5.39e-07	2.99e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—hypertension	5.38e-07	2.99e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—AKT1—hypertension	5.38e-07	2.98e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—EGFR—hypertension	5.31e-07	2.95e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MTOR—hypertension	5.29e-07	2.94e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VEGFA—hypertension	5.28e-07	2.93e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—AKT1—hypertension	5.22e-07	2.89e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALDH2—hypertension	5.19e-07	2.88e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MYC—hypertension	5.16e-07	2.87e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFB1—hypertension	5.15e-07	2.86e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—hypertension	5.1e-07	2.83e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL8—hypertension	5.08e-07	2.82e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HBA1—hypertension	5.06e-07	2.81e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EGFR—hypertension	5.05e-07	2.8e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP11A1—hypertension	5.02e-07	2.79e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—hypertension	5.02e-07	2.79e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MYC—hypertension	5.01e-07	2.78e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFB1—hypertension	5e-07	2.78e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—AKT1—hypertension	4.96e-07	2.76e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTT1—hypertension	4.93e-07	2.74e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC9A1—hypertension	4.93e-07	2.74e-06	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AKT1—hypertension	4.91e-07	2.73e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EGFR—hypertension	4.9e-07	2.72e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GCLC—hypertension	4.88e-07	2.71e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CETP—hypertension	4.88e-07	2.71e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MYC—hypertension	4.86e-07	2.7e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFB1—hypertension	4.85e-07	2.69e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—hypertension	4.83e-07	2.68e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EGFR—hypertension	4.76e-07	2.64e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AKT1—hypertension	4.71e-07	2.61e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP17A1—hypertension	4.67e-07	2.59e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AKT1—hypertension	4.63e-07	2.57e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS1—hypertension	4.62e-07	2.57e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ENO1—hypertension	4.62e-07	2.57e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—hypertension	4.6e-07	2.55e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CDKN1A—hypertension	4.58e-07	2.54e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PTEN—hypertension	4.57e-07	2.54e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MAPK8—hypertension	4.47e-07	2.48e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AKT1—hypertension	4.46e-07	2.48e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CTGF—hypertension	4.45e-07	2.47e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—hypertension	4.42e-07	2.45e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GOT2—hypertension	4.41e-07	2.45e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HMGCR—hypertension	4.41e-07	2.45e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EP300—hypertension	4.36e-07	2.42e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADRA2A—hypertension	4.32e-07	2.4e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TP53—hypertension	4.24e-07	2.35e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SRC—hypertension	4.24e-07	2.35e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VEGFA—hypertension	4.13e-07	2.29e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TP53—hypertension	4.12e-07	2.29e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—hypertension	4.08e-07	2.26e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—AKT1—hypertension	4.07e-07	2.26e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TH—hypertension	4.04e-07	2.24e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CALM2—hypertension	4.03e-07	2.24e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TP53—hypertension	3.99e-07	2.22e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC2A4—hypertension	3.93e-07	2.18e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GCG—hypertension	3.93e-07	2.18e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—hypertension	3.88e-07	2.15e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GOT1—hypertension	3.81e-07	2.11e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MYC—hypertension	3.8e-07	2.11e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFB1—hypertension	3.79e-07	2.1e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—hypertension	3.77e-07	2.09e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—AKT1—hypertension	3.76e-07	2.09e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EGFR—hypertension	3.72e-07	2.06e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—STK11—hypertension	3.7e-07	2.05e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP19A1—hypertension	3.7e-07	2.05e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—hypertension	3.65e-07	2.03e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AKT1—hypertension	3.58e-07	1.99e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AKT1—hypertension	3.48e-07	1.93e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—COMT—hypertension	3.44e-07	1.91e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GNB3—hypertension	3.39e-07	1.88e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PPARGC1A—hypertension	3.39e-07	1.88e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HMOX1—hypertension	3.37e-07	1.87e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AKT1—hypertension	3.37e-07	1.87e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CAT—hypertension	3.33e-07	1.85e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GNAS—hypertension	3.3e-07	1.83e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOB—hypertension	3.23e-07	1.79e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTM1—hypertension	3.14e-07	1.74e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TP53—hypertension	3.12e-07	1.73e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LPL—hypertension	3.08e-07	1.71e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADCY5—hypertension	3.02e-07	1.68e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GPX1—hypertension	3.01e-07	1.67e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PRKCA—hypertension	2.98e-07	1.65e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP1A1—hypertension	2.98e-07	1.65e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CD36—hypertension	2.93e-07	1.63e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—hypertension	2.86e-07	1.59e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTHFR—hypertension	2.78e-07	1.54e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PPARA—hypertension	2.72e-07	1.51e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AGT—hypertension	2.64e-07	1.46e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AKT1—hypertension	2.63e-07	1.46e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CALM1—hypertension	2.59e-07	1.44e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOE—hypertension	2.59e-07	1.44e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CAV1—hypertension	2.56e-07	1.42e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOA1—hypertension	2.56e-07	1.42e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PPARG—hypertension	2.25e-07	1.25e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—hypertension	2.22e-07	1.23e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—INS—hypertension	2.21e-07	1.23e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALB—hypertension	2.03e-07	1.12e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—hypertension	1.94e-07	1.08e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PIK3R1—hypertension	1.94e-07	1.08e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—hypertension	1.77e-07	9.84e-07	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTEN—hypertension	1.55e-07	8.58e-07	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—EP300—hypertension	1.47e-07	8.18e-07	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AKT1—hypertension	8.91e-08	4.94e-07	CbGpPWpGaD
